1
µL, 10 mmol) was added, and the mixture was further stirred for
12 h. The reaction mixture was then diluted with CH2Cl2 (100 mL)
and H2O (50 mL), then neutralized with aqueous 1 M solution of
NaOH at 0 °C. The aqueous phase was extracted with CH2Cl2 (2
× 20 mL). The combined organic phases were washed with aqueous
1 M NaOH (40 mL), H2O (50 mL), and brine (2 × 50 mL), dried
over Na2SO4, filtered, and evaporated to furnish products of good
to excellent purity. Further purification and/or product separation
was carried out by column chromatography (Supporting Informa-
tion).
General Procedure B for SIBX-Mediated HPD of 2-Alky-
lphenols. To a solution of 2-alkylphenol (10 mmol) in THF (25
mL) was added SIBX (6.875 g, i.e., 11 mmol of IBX) as a solid in
one portion. The resulting suspension was stirred at room temper-
ature for 24 h, after which time TFA (780 µL, 10 mmol) was added,
and the mixture was further stirred for 12 h. The reaction mixture
was then diluted with CH2Cl2 (100 mL) and H2O (50 mL). An
aqueous 1 M solution of NaOH was added slowly and continuously
with vigorous shaking until all solid material dissolved. The aqueous
phase was extracted with CH2Cl2 (3 × 20 mL). The combined
organic phases were washed with aqueous 1 M NaOH (40 mL),
H2O (50 mL), and brine (2 × 50 mL), then shaken vigorously with
a saturated aqueous solution of Na2S2O4 (100 mL), washed again
with brine (50 mL), dried over Na2SO4, filtered, and evaporated at
room temperature to give a residue, which was then purified by
column chromatography.
(()-Grandifloracin (9i). To an ice-cooled solution of salicylic
alcohol (124 mg, 1 mmol) in CH2Cl2 (5 mL) were added Et3N (144
µL, 1 mmol) and benzoyl chloride (117 µL, 1 mmol). The resulting
mixture was stirred at room temperature for 24 h, after which time
it was quenched with a saturated aqueous solution of NH4Cl (20
mL), washed with brine (20 mL), dried over MgSO4, filtered, and
evaporated to give a crude brown oil (250 mg). Purification by
column chromatography, eluting with hexanes/acetone from (10:
1) to (3:1), gave 2-hydroxybenzyl benzoate (7i)24 as a colorless oil
(93 mg, 41%). This phenolic benzoate 7i (456 mg, 2 mmol gathered
from several runs) was then submitted to the SIBX-mediated HPD
reaction according to the general procedure B apart from the fact
that a saturated aqueous solution of Na2CO3 was used instead of
an aqueous 1 M solution of NaOH during the workup. Purification
by column chromatography, eluting with hexanes/acetone (3:1),
afforded a solid residue that was then crystallized from a mixture
of CH2Cl2 and hexanes to give pure (()-grandifloracin (9i) as white
fines crystals (146 mg, 30%). mp 188-188.5 °C (lit.7 mp 161-
163 °C); Rf ) 0.20 [hexanes/acetone, (3:1)]; IR (NaCl, neat) 3450,
1720, 1711, 1683, 1620 cm-1; 1H NMR (CDCl3, 300 MHz) δ 3.20-
3.35 (m, 3H), 3.69 (d, J ) 6.8 Hz, 1H), 4.23 (d, J ) 12.0 Hz, 1H),
4.40-4.43 (m, 2H), 4.46 (d, J ) 12.0 Hz, 1H), 6.00 (t, J ) 6.7
Hz, 1H), 6.20 (d, J ) 9.8 Hz, 1H), 6.43 (t, J ) 7.2 Hz, 1H), 6.58
(dd, J ) 3.6, 10.0 Hz, 1H), 7.92 (d, J ) 7.3 Hz, 2H), 8.05 (d, J )
7.3 Hz, 2H); 13C NMR (CDCl3, 75 MHz) δ 208.1, 198.1, 166.6,
165.8, 146.7, 135.1, 133.4, 133.3, 129.8, 129.7, 129.3, 129.2, 128.5,
128.5, 128.4, 128.0, 75.4, 74.4, 71.8, 68.1, 52.1, 41.0, 39.9, 37.3;
ESIMS (MeOH) m/z (relative intensity) 511 [MNa+, 100]; HRMS
(ESIMS) calcd for C28H24O8Na+ 511.1369, found 511.1365.
cm-1; H NMR (CDCl3, 300 MHz) δ 3.69 (s, 3H), 6.12 (d, J )
9.8 Hz, 1H), 6.73 (d, J ) 9.8 Hz, 1H), 7.26 (d, J ) 7.5 Hz, 1H),
7.39 (dt, J ) 0.7, 7.5 Hz, 1H), 7.62 (dt, J ) 1.1, 7.5 Hz, 1H), 7.98
(d, J ) 7.5 Hz, 1H); 13C NMR (CDCl3, 75.5 MHz) δ 196.6, 169.7,
137.5, 135.5, 129.7, 129.0, 128.8, 128.1, 127.8, 127.5, 77.8, 53.7;
EIMS m/z (relative intensity) 218 (M+, 21), 159 (30), 131 (100);
HRMS (EI) calcd for C12H10O4 218.0579, found 218.0591.
2-Hydroxy-2-[(2-methyloxiran-2-yl)methyl]naphthalen-1(2H)-
one (14). To a solution of naphthol 11d (60 mg, 0.28 mmol) in
THF (2 mL) at 0 °C was added SIBX (176 mg, 0.31 mmol) as a
solid in one portion. The resulting suspension was stirred at 0 °C
for 14 h, after which time it was poured into ice-cold water (2
mL). This mixture was treated with aqueous 1 M NaOH, which
was added dropwise until pH near 9 was reached, and separated,
and the aqueous phase was extracted with EtOAc (20 mL). The
combined organic phases were washed with water (20 mL), dried
over Na2SO4, and evaporated to afford orthoquinol 14 (65 mg,
100%) as a mixture (∼50:50) of two diastereoisomers: IR (NaCl,
neat) 3428, 1716 cm-1; H NMR (CDCl3, 400 MHz) δ 1.40 (s,
1
3H), 1.39 (s, 3H), 1.75 (d, J ) 14.2 Hz, 1H), 1.88 (d, J ) 14.2 Hz,
1H), 2.00 (d, J ) 14.1 Hz, 1H), 2.17 (d, J ) 14.4 Hz, 1H), 2.50 (s,
2H), 2.54 (d, J ) 4.6 Hz, 1H), 2.67 (d, J ) 4.6 Hz, 1H), 3.62 (s,
1H), 3.62 (s, 1H), 6.31-6.38 (m, 2H), 6.48-6.51 (m, 2H), 7.19
(dd, J ) 3.0, 7.1 Hz, 2H), 7.34 (t, J ) 7.6 Hz, 2H), 7.56 (t, J ) 7.6
Hz, 2H), 7.91 (t, J ) 6.8 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ
203.80, 203.77, 137.5, 137.3, 136.0, 135.8, 135.1, 135.1, 128.4,
128.3, 127.5, 127.3, 127.2, 127.0, 124.8, 124.8, 74.4, 54.9, 54.6,
54.4, 54.2, 48.3, 47.9, 22.9, 22.6; EIMS m/z (relative intensity) 230.2
(M+, 3), 213 (6), 131 (100); HMRS (EI) calcd for C14H14O3
230.0943, found 230.0951.
2-Hydroxy-2-[(2-tert-butyldimethylsilyloxy-3-cyano)propyl]-
naphthalen-1(2H)-one (15). To a solution of naphthol 11e (46 mg,
0.135 mmol) in THF (2 mL) at 0 °C was added SIBX (85 mg,
0.15 mmol) as a solid in one portion. The resulting suspension was
stirred at 0 °C for 14 h, after which time it was poured into ice-
cold water (2 mL). This mixture was treated with aqueous 1 M
NaOH, which was added dropwise until pH near 9 was reached,
and separated, and the aqueous phase was extracted with EtOAc
(20 mL). The combined organic phases were washed with water
(20 mL), dried over Na2SO4, and evaporated to afford orthoquinol
15 as a mixture (∼60:40) of two diastereoisomers (40 mg, 83%):
IR (NaCl, neat) 3461, 2252, 1689 cm-1; H NMR (CDCl3, 400
1
MHz) δ 7.91 (bt, 1H), 7.59 (bt, 1H), 7.36 (bd, 1H), 7.20 (bd, 1H),
6.51 (d, J ) 10 Hz, 1H, minor), 6.47 (d, J ) 9.8 Hz, 1H, major),
6.31 (d, J ) 9.8 Hz, 1H, minor), 6.27 (d, J ) 9.8 Hz, 1H, major),
4.25 (m, 1H, minor), 4.11 (m, 1H, major), 2.79-2.52 (m, 2H),
2.18-1.76 (m, 1H), 0.86 (s, 9H, minor), 0.82 (s, 9H, major), 0.10
(s, 3H, minor), 0.06 (s, 3H, minor), 0.05 (s, 3H, major), -0.06 (s,
3H, major); 13C NMR (CDCl3, 100 MHz) δ 203.7, 203.5, 137.34,
137.31, 136.3, 135.42, 135.39, 135.36, 128.55, 128.45, 128.2,
127.49, 127.45, 127.3, 125.1, 124.9, 117.7, 117.4, 65.5, 64.7, 47.4,
46.5, 27.7, 27.3, 25.6, 0.97, -4.66, -4.74, -4.85, -4.89; HMRS
(ESI) calcd for C20H27NO3Si 357.1760, found 357.1773.
Acknowledgment. We thank the Institut Universitaire de
France, the Ministe`re de la Recherche, the Centre National de
la Recherche Scientifique (“Jeunes Chercheurs” ATIP Grant
2005-2007), the Association Nationale de la Recherche Tech-
nique (CIFRE Grant No. 301/2002), and Simafex for their
financial support.
Methyl 1,2-Dihydro-2-hydroxy-1-oxonaphthalene-2-carboxy-
late (13). To a solution of naphthol 11c (50 mg, 0.25 mmol) in
EtOAc (1.5 mL) was added SIBX (310 mg, 0.52 mmol) as a solid
in one portion. The resulting suspension was stirred at 50 °C for 7
days, after which time it was diluted with EtOAc (20 mL), washed
with saturated aqueous NaHCO3 (3 × 5 mL) and brine (5 mL),
dried over Na2SO4, filtered, and evaporated to give an oily residue
(109 mg). This residue was then purified by column chromatog-
raphy, eluting with cyclohexane/acetone (1:2), to furnish orthoquinol
13 (37 mg, 74%) as an orange oil. IR (NaCl) 3491, 1748, 1224
Supporting Information Available: Additional experimental
details, characterization data and H and 13C NMR spectra for all
1
compounds, ORTEP diagrams of all new X-ray crystal structures
(9b, 9c, 9e, 9h, CCDC 640072-75), and their corresponding CIFs.
This material is available free of charge via the Internet at
(24) Sekine, M.; Kume, A.; Hata, T. Tetrahedron Lett. 1981, 22, 3617-
3620.
JO0708893
J. Org. Chem, Vol. 72, No. 16, 2007 6283